ArticleResearch square2026

Intranasal CRISPR- lipid nanoparticles targeting MAPK9 reduce neuroinflammation after traumatic brain injury.

Goknur Kara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.